Navigation Links
How did cactuses evolve?

In a groundbreaking new study in the June issue of American Naturalist, Erika J. Edwards (Yale University and University of California, Santa Barbara) and Michael J. Donoghue (Yale University) explore how leafy, "normal" plants evolved into the leafless succulent cactus.

"The cactus form is often heralded as a striking example of the tight relationship between form and function in plants," write the authors. "A succulent, long-lived photosynthetic system allows cacti to survive periods of extreme drought while maintaining well-hydrated tissues."

Recent molecular phylogenetic work has confirmed that Pereskia, a genus that consists of 17 species of leafy shrubs and trees, is where the earliest cactus lineages began. Using field studies and environmental modeling, Edwards and Donoghue found that the Pereskia species already showed water use patterns that are similar to the leafless, stem-succulent cacti.

"[Our] analyses suggest that several key elements of cactus ecological function were established prior to the evolution of the cactus life form," explain the authors. "Such a sequence may be common in evolution, but it has rarely been documented as few studies have incorporated physiological, ecological, anatomical, and phylogenetic data."


'"/>

Source:University of Chicago Press Journals


Page: 1

Related biology news :

1. Growth hormone is made in the brain, report scientists
2. Electronic chip, interacting with the brain, modifies pathways for controlling movement
3. Seals protect brain, conserve oxygen by turning off shivering response on icy dives
4. Neuronal traffic jam marks early Alzheimers disease
5. Discovery of T-cell traffic control boosts new drug promise
6. Cells direct membrane traffic by channel width
7. Bugs expose underground carbon traffic system 10 times more important than fossil fuel burning
8. Molecular mechanism provides intra-cellular traffic signal
9. Cellular traffic backups implicated in skeletal malformations
10. New imaging technique tracks traffic patterns of white blood cells
11. A traffic light for neurons means go for improving brain research
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: